PlainRecalls
FDA Drug Moderate Class II Ongoing

Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30

Reported: October 22, 2025 Initiated: October 8, 2025 #D-0028-2026

Product Description

Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30

Reason for Recall

Lack of Assurance of Sterility:

Details

Units Affected
916 pre-filled syringes
Distribution
Nationwide in the U.S
Location
Gaithersburg, MD

Frequently Asked Questions

What product was recalled?
Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30. Recalled by ASTRAZENECA PHARMACEUTICALS. Units affected: 916 pre-filled syringes.
Why was this product recalled?
Lack of Assurance of Sterility:
Which agency issued this recall?
This recall was issued by the FDA Drug on October 22, 2025. Severity: Moderate. Recall number: D-0028-2026.